The current valuation score of Vir Biotechnology Inc is 7.63, ranking 157 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.76, which is -387.09% below the recent high of 7.93 and -804.98% above the recent low of -25.00.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.